Eric Tu - Concepedia

Author

Eric Tu

National Institute of Dental and Craniofacial Research

Also Known As

Durham, Nicholas, Eric Tu

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

National Institute of Dental and Craniofacial Research National Institutes of Health AstraZeneca (Japan)AstraZeneca (United Kingdom)Nanjing Drum Tower Hospital

About

Eric Tu is an author at National Institute of Dental and Craniofacial Research specializing in immunology, medicine, and immune regulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	485
2	Health Sciences	2	2	291
3	Cell Biology	2	2	167
4	Allergy	1	1	27
5	Cellular Therapies	1	1	40

Eric Tu

Publications

746

Citations

H-Index

Page 1

	Year	Citations
High Glucose Intake Exacerbates Autoimmunity through Reactive-Oxygen-Species-Mediated TGF-β Cytokine Activation Dunfang Zhang, Wenwen Jin, Ruiqing Wu, Immunity InflammationMetabolic SyndromeAutoimmune DiseasePhysiologyImmunology	2019	251
Anti–PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC Eric Tu, Kelly McGlinchey, Jixin Wang, JCI Insight	2022	102
T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation Eric Tu, Cheryl Chia, Weiwei Chen, Immunity Signal TransductionAdaptive Immune SystemImmunologyImmune RegulationT Cell Immunity	2018	90
The DNA-binding inhibitor Id3 regulates IL-9 production in CD4+ T cells Hiroko Nakatsukasa, Dunfang Zhang, Takashi Maruyama, Nature Immunology InflammationAutoimmune DiseaseImmune Cell DevelopmentT-regulatory CellImmune Regulation	2015	77
Extracellular Vesicles from Apoptotic Cells Promote TGFβ Production in Macrophages and Suppress Experimental Colitis Hua Chen, Shimpei Kasagi, Cheryl Chia, Scientific Reports	2019	50
Phase I study of C-CAR031, a GPC3-specific TGFβRIIDN armored autologous CAR-T, in patients with advanced hepatocellular carcinoma (HCC). Qi Zhang, Qihan Fu, Wanyue Cao, Journal of Clinical Oncology Clinical ImmunologyCell TherapyImmunologyPathologyImmunotherapeutics	2024	40
PARP-1 regulates expression of TGF-β receptors in T cells Pin Zhang, Hiroko Nakatsukasa, Eric Tu, Blood	2013	39
Antitumor activity of AZD0754, a dnTGFβRII-armored, STEAP2-targeted CAR-T cell therapy, in prostate cancer Peter Zanvit, Dewald van Dyk, Christine Fazenbaker, Journal of Clinical Investigation	2023	39
Both <scp>IFN</scp>‐γ and <scp>IL</scp>‐17 are required for the development of severe autoimmune gastritis Eric Tu, Desmond K. Y. Ang, Shayne A. Bellingham, European Journal of Immunology Clinical ImmunologyHelper TImmunodeficienciesT-regulatory CellImmunology	2012	27
Phase I study of a recombinant attenuated oncolytic virus, MEDI5395 (NDV–GM-CSF), administered systemically in combination with durvalumab in patients with advanced solid tumors Diwakar Davar, Benedito A. Carneiro, Grace K. Dy, Journal for ImmunoTherapy of Cancer	2024	17

Page 1